- Home
- GRVY vs DNA Comparison
GRVY vs DNA Comparison
Compare GRVY & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRVY
- DNA
- Stock Information
- Founded
- GRVY 2000
- DNA 2008
- Country
- GRVY South Korea
- DNA United States
- Employees
- GRVY N/A
- DNA N/A
- Industry
- GRVY Business Services
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GRVY Consumer Discretionary
- DNA Health Care
- Exchange
- GRVY Nasdaq
- DNA Nasdaq
- Market Cap
- GRVY 421.6M
- DNA 466.4M
- IPO Year
- GRVY 2005
- DNA N/A
- Fundamental
- Price
- GRVY $64.22
- DNA $8.11
- Analyst Decision
- GRVY
- DNA Sell
- Analyst Count
- GRVY 0
- DNA 5
- Target Price
- GRVY N/A
- DNA $17.25
- AVG Volume (30 Days)
- GRVY 10.8K
- DNA 1.1M
- Earning Date
- GRVY 05-09-2025
- DNA 05-06-2025
- Dividend Yield
- GRVY N/A
- DNA N/A
- EPS Growth
- GRVY N/A
- DNA N/A
- EPS
- GRVY 8.27
- DNA N/A
- Revenue
- GRVY $326,731,939.00
- DNA $237,417,000.00
- Revenue This Year
- GRVY N/A
- DNA N/A
- Revenue Next Year
- GRVY N/A
- DNA $16.74
- P/E Ratio
- GRVY $7.96
- DNA N/A
- Revenue Growth
- GRVY N/A
- DNA 13.76
- 52 Week Low
- GRVY $53.12
- DNA $5.00
- 52 Week High
- GRVY $88.85
- DNA $38.60
- Technical
- Relative Strength Index (RSI)
- GRVY 64.20
- DNA 56.32
- Support Level
- GRVY $59.75
- DNA $6.42
- Resistance Level
- GRVY $61.00
- DNA $8.43
- Average True Range (ATR)
- GRVY 1.39
- DNA 0.60
- MACD
- GRVY 0.56
- DNA 0.11
- Stochastic Oscillator
- GRVY 78.44
- DNA 84.29
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.